Question 1

How many shares of SYRE does FARALLON CAPITAL MANAGEMENT, L.L.C. own?

Accepted Answer

FARALLON CAPITAL MANAGEMENT, L.L.C. previously held 0 shares of SYRE (Spyre Therapeutics, Inc) before exiting the position in 2024-Q3.

Question 2

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s SYRE position worth?

Accepted Answer

FARALLON CAPITAL MANAGEMENT, L.L.C.'s SYRE position was last reported at $0 in 2024-Q3 before the exit.

Question 3

Is FARALLON CAPITAL MANAGEMENT, L.L.C. buying or selling SYRE?

Accepted Answer

In 2024-Q3, FARALLON CAPITAL MANAGEMENT, L.L.C. exited their SYRE position entirely (-100.0% change in shares).

Question 4

When did FARALLON CAPITAL MANAGEMENT, L.L.C. first buy SYRE?

Accepted Answer

Based on available 13F filings, FARALLON CAPITAL MANAGEMENT, L.L.C. first reported a position in SYRE in 2024-Q3. They have held the position across 3 quarters.